ProtoKinetix Inc. Stock Analysis PKTX
Protokinetix, Inc. is a research and development stage biotechnology company engaged in the scientific medical research of anti-aging glycoproteins. The company is headquartered in Dalton, Ohio. The company went IPO on 2002-01-07. Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins. The firm's anti-aging glycopeptide is for ophthalmology, dermatology, transplant support and biomanufacturing. The commercial applications for AAGPs include various health care solutions. The firm has not developed a commercially viable product and has not generated any revenue.
Read More ProtoKinetix Inc (PKTX) Chart
Key Statistics of ProtoKinetix Inc (PKTX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.01Volume
15.50KP/E Ratio (TTM)
-52 Week Range
Market Cap
2.11MAvg. Volume
73.93KDividend Yield
-Financial Metrics & Statements of ProtoKinetix Inc (PKTX)
FAQ's for ProtoKinetix Inc (PKTX)
- According to Musaffa’s Shariah screening methodology, ProtoKinetix Inc (PKTX) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.